Que Chi Truong-Bolduc, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Staphylococcus aureus | 27 | 2024 | 1458 | 6.170 |
Why?
|
Bacterial Proteins | 23 | 2024 | 3846 | 2.690 |
Why?
|
Membrane Transport Proteins | 11 | 2024 | 1035 | 2.610 |
Why?
|
Staphylococcal Infections | 9 | 2024 | 1407 | 2.320 |
Why?
|
Gene Expression Regulation, Bacterial | 15 | 2024 | 1133 | 1.720 |
Why?
|
Microbial Sensitivity Tests | 14 | 2024 | 1937 | 1.600 |
Why?
|
Multidrug Resistance-Associated Proteins | 6 | 2024 | 105 | 1.110 |
Why?
|
Anti-Bacterial Agents | 18 | 2024 | 7409 | 0.940 |
Why?
|
Phenazines | 1 | 2024 | 56 | 0.940 |
Why?
|
Ciprofloxacin | 5 | 2021 | 312 | 0.860 |
Why?
|
Tetracycline | 5 | 2024 | 216 | 0.830 |
Why?
|
Pseudomonas aeruginosa | 3 | 2024 | 1277 | 0.800 |
Why?
|
Toll-Like Receptor 2 | 2 | 2019 | 347 | 0.680 |
Why?
|
Congo Red | 1 | 2019 | 48 | 0.660 |
Why?
|
Tunicamycin | 1 | 2019 | 108 | 0.660 |
Why?
|
Pseudomonas Infections | 1 | 2024 | 622 | 0.650 |
Why?
|
Genes, Regulator | 3 | 2011 | 374 | 0.650 |
Why?
|
Teichoic Acids | 1 | 2019 | 70 | 0.640 |
Why?
|
Fosfomycin | 1 | 2018 | 24 | 0.620 |
Why?
|
Transcription, Genetic | 6 | 2017 | 7595 | 0.530 |
Why?
|
Epithelial Cells | 3 | 2017 | 3667 | 0.520 |
Why?
|
Phagosomes | 1 | 2017 | 199 | 0.510 |
Why?
|
Escherichia coli Proteins | 1 | 2022 | 1067 | 0.490 |
Why?
|
Staphylococcal Skin Infections | 2 | 2014 | 78 | 0.450 |
Why?
|
Host-Pathogen Interactions | 2 | 2021 | 1458 | 0.400 |
Why?
|
Drug Resistance, Bacterial | 7 | 2018 | 1048 | 0.390 |
Why?
|
Aza Compounds | 1 | 2011 | 34 | 0.380 |
Why?
|
Oxidoreductases | 1 | 2012 | 413 | 0.330 |
Why?
|
Drug Resistance, Multiple, Bacterial | 4 | 2024 | 587 | 0.320 |
Why?
|
Promoter Regions, Genetic | 8 | 2017 | 5789 | 0.310 |
Why?
|
Trans-Activators | 2 | 2017 | 2856 | 0.310 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2012 | 1171 | 0.280 |
Why?
|
beta-Lactams | 2 | 2024 | 155 | 0.270 |
Why?
|
Quinolines | 1 | 2011 | 764 | 0.250 |
Why?
|
Genes, Bacterial | 2 | 2007 | 1073 | 0.250 |
Why?
|
Protein Binding | 6 | 2019 | 9352 | 0.250 |
Why?
|
Repressor Proteins | 3 | 2014 | 2985 | 0.250 |
Why?
|
Fluoroquinolones | 4 | 2013 | 307 | 0.240 |
Why?
|
Microbial Viability | 2 | 2017 | 238 | 0.240 |
Why?
|
Oxacillin | 1 | 2024 | 41 | 0.230 |
Why?
|
Protein Processing, Post-Translational | 2 | 2012 | 1974 | 0.230 |
Why?
|
Nafcillin | 1 | 2024 | 23 | 0.230 |
Why?
|
Pyocyanine | 1 | 2024 | 20 | 0.230 |
Why?
|
beta-Lactam Resistance | 1 | 2024 | 73 | 0.230 |
Why?
|
Klebsiella pneumoniae | 1 | 2024 | 250 | 0.200 |
Why?
|
beta-Lactamases | 1 | 2024 | 304 | 0.200 |
Why?
|
Quinolones | 4 | 2007 | 378 | 0.200 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 4575 | 0.190 |
Why?
|
Mupirocin | 1 | 2021 | 55 | 0.190 |
Why?
|
Electrophoretic Mobility Shift Assay | 3 | 2014 | 293 | 0.190 |
Why?
|
Escherichia coli | 2 | 2024 | 4218 | 0.180 |
Why?
|
Chlorhexidine | 1 | 2021 | 160 | 0.180 |
Why?
|
DNA-Binding Proteins | 1 | 2018 | 9606 | 0.180 |
Why?
|
Oxygen | 1 | 2012 | 4228 | 0.170 |
Why?
|
Molecular Sequence Data | 8 | 2014 | 17644 | 0.170 |
Why?
|
Norfloxacin | 2 | 2010 | 24 | 0.170 |
Why?
|
Potassium | 1 | 2022 | 1311 | 0.150 |
Why?
|
Chloramphenicol | 1 | 2017 | 67 | 0.150 |
Why?
|
Ornithine | 1 | 2017 | 79 | 0.150 |
Why?
|
ATP-Binding Cassette Transporters | 2 | 2014 | 563 | 0.140 |
Why?
|
Erythromycin | 1 | 2017 | 115 | 0.140 |
Why?
|
Citrates | 1 | 2017 | 135 | 0.140 |
Why?
|
Sodium | 1 | 2022 | 1588 | 0.140 |
Why?
|
Genetic Fitness | 1 | 2017 | 115 | 0.130 |
Why?
|
Abscess | 2 | 2017 | 606 | 0.130 |
Why?
|
Base Sequence | 5 | 2014 | 12450 | 0.130 |
Why?
|
Structure-Activity Relationship | 1 | 2021 | 3076 | 0.130 |
Why?
|
Chloroquine | 1 | 2017 | 274 | 0.130 |
Why?
|
Biological Transport, Active | 2 | 2006 | 328 | 0.120 |
Why?
|
Protein Kinases | 1 | 2022 | 1607 | 0.120 |
Why?
|
Gene Knockout Techniques | 1 | 2018 | 802 | 0.120 |
Why?
|
Polyamines | 1 | 2013 | 133 | 0.110 |
Why?
|
DNA, Bacterial | 1 | 2018 | 1479 | 0.100 |
Why?
|
Lipopolysaccharides | 1 | 2019 | 2207 | 0.100 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2014 | 2498 | 0.090 |
Why?
|
Anti-Infective Agents | 2 | 2005 | 982 | 0.070 |
Why?
|
Gluconates | 1 | 2007 | 31 | 0.070 |
Why?
|
Genes, MDR | 1 | 2007 | 36 | 0.070 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2010 | 1693 | 0.070 |
Why?
|
Stress, Physiological | 1 | 2014 | 1403 | 0.070 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2021 | 5305 | 0.060 |
Why?
|
Fatty Acids | 1 | 2013 | 1808 | 0.060 |
Why?
|
Topoisomerase II Inhibitors | 1 | 2005 | 94 | 0.060 |
Why?
|
Amino Acid Sequence | 3 | 2007 | 13449 | 0.060 |
Why?
|
Transcription Factors | 2 | 2014 | 12125 | 0.060 |
Why?
|
Tetracyclines | 1 | 2005 | 64 | 0.060 |
Why?
|
Mice, Inbred BALB C | 1 | 2013 | 6215 | 0.060 |
Why?
|
Ceftazidime | 1 | 2024 | 57 | 0.060 |
Why?
|
RNA, Messenger | 3 | 2006 | 12796 | 0.060 |
Why?
|
RNA, Bacterial | 1 | 2006 | 393 | 0.060 |
Why?
|
Pyrrolidines | 1 | 2005 | 338 | 0.060 |
Why?
|
Humans | 9 | 2024 | 761423 | 0.060 |
Why?
|
Blotting, Western | 1 | 2011 | 5036 | 0.060 |
Why?
|
Cell Line | 1 | 2017 | 15605 | 0.050 |
Why?
|
Mass Spectrometry | 1 | 2008 | 2192 | 0.050 |
Why?
|
Mutation | 6 | 2017 | 30045 | 0.050 |
Why?
|
Substrate Specificity | 1 | 2005 | 1791 | 0.050 |
Why?
|
Mice | 4 | 2017 | 81509 | 0.050 |
Why?
|
Sequence Alignment | 1 | 2005 | 2179 | 0.050 |
Why?
|
Flow Cytometry | 1 | 2011 | 5868 | 0.040 |
Why?
|
Gene Expression | 1 | 2013 | 7584 | 0.040 |
Why?
|
Haemophilus Vaccines | 1 | 2000 | 71 | 0.040 |
Why?
|
Cloning, Molecular | 1 | 2006 | 4174 | 0.040 |
Why?
|
Antigenic Variation | 1 | 2000 | 118 | 0.040 |
Why?
|
Haemophilus influenzae | 1 | 2000 | 178 | 0.040 |
Why?
|
Skin | 1 | 2013 | 4481 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2017 | 9179 | 0.040 |
Why?
|
5' Untranslated Regions | 1 | 2001 | 256 | 0.040 |
Why?
|
Gene Expression Profiling | 2 | 2014 | 9418 | 0.040 |
Why?
|
Phosphorylation | 1 | 2010 | 8320 | 0.040 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 16979 | 0.040 |
Why?
|
Otitis Media | 1 | 2000 | 287 | 0.040 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2000 | 406 | 0.040 |
Why?
|
Phylogeny | 1 | 2005 | 2811 | 0.040 |
Why?
|
Iron | 2 | 2017 | 1792 | 0.040 |
Why?
|
Siderophores | 1 | 2017 | 61 | 0.040 |
Why?
|
Genetic Complementation Test | 1 | 2017 | 555 | 0.030 |
Why?
|
Animals | 5 | 2017 | 168441 | 0.030 |
Why?
|
Child | 1 | 2024 | 80162 | 0.030 |
Why?
|
Bambermycins | 1 | 2014 | 11 | 0.030 |
Why?
|
Binding Sites | 1 | 2003 | 6055 | 0.030 |
Why?
|
Korea | 1 | 2013 | 98 | 0.030 |
Why?
|
Cell Membrane | 1 | 2003 | 3687 | 0.030 |
Why?
|
Plasmids | 1 | 2017 | 2269 | 0.020 |
Why?
|
DNA Topoisomerases, Type II | 1 | 2005 | 122 | 0.020 |
Why?
|
Naphthyridines | 1 | 2005 | 143 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2014 | 3110 | 0.010 |
Why?
|
Transformation, Bacterial | 1 | 2000 | 76 | 0.010 |
Why?
|
Chinchilla | 1 | 2000 | 75 | 0.010 |
Why?
|
Hospitals | 1 | 2013 | 3882 | 0.010 |
Why?
|
Ear, Middle | 1 | 2000 | 339 | 0.010 |
Why?
|
Mutagenesis, Insertional | 1 | 2000 | 656 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2000 | 2748 | 0.010 |
Why?
|
Male | 1 | 2013 | 360736 | 0.010 |
Why?
|
Drug Design | 1 | 2000 | 1048 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18247 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2000 | 6532 | 0.010 |
Why?
|
Vaccination | 1 | 2000 | 3381 | 0.000 |
Why?
|